🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, claiming the corporations withheld safety concerns that the pain reliever created to pediatric brain development.

The lawsuit comes thirty days after Donald Trump promoted an unproven link between using Tylenol - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in offspring.

Paxton is suing the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and Kenvue, which now manufacturers it.

In a declaration, he stated they "deceived the public by profiting off of discomfort and promoting medication regardless of the potential hazards."

Kenvue states there is lacking scientific proof connecting Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, stated.

The company commented that it was "seriously troubled by the spread of false claims on the security of paracetamol and the potential impact that could have on the well-being of American women and children."

On its website, Kenvue also said it had "regularly reviewed the relevant science and there is no credible data that demonstrates a proven link between consuming paracetamol and autism."

Organizations speaking for physicians and health professionals concur.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is one of the few options for expectant mothers to treat pain and elevated temperature, which can present major wellness concerns if not addressed.

"In over twenty years of research on the utilization of acetaminophen in gestation, not a single reputable study has successfully concluded that the consumption of acetaminophen in any period of pregnancy causes neurological conditions in young ones," the group said.

The lawsuit mentions latest statements from the Trump administration in claiming the drug is potentially dangerous.

Recently, the former president raised alarms from public health officials when he instructed women during pregnancy to "resist strongly" not to use Tylenol when unwell.

Federal regulators then issued a notice that physicians should think about restricting the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism in young ones has remains unverified.

The Health Department head RFK Jr, who supervises the FDA, had promised in April to initiate "comprehensive study program" that would identify the cause of autism in a limited time.

But specialists cautioned that identifying a single cause of autism - believed by scientists to be the outcome of a intricate combination of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that influences how people encounter and interact with the surroundings, and is identified using doctors' observations.

In his legal document, Paxton - who supports Trump who is campaigning for the Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around acetaminophen and autism.

The case aims to force the companies "destroy any promotional materials" that claims acetaminophen is reliable for expectant mothers.

This legal action echoes the complaints of a assembly of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in two years ago.

The court threw out the case, saying studies from the parents' expert witnesses was lacking definitive proof.